Collegium Pharma (COLL) Reports Q4 Loss of $1.02/Share
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Join SI Premium – FREE
Collegium Pharma (NASDAQ: COLL) reported Q4 EPS of ($1.02), versus ($0.46) reported last year.
For earnings history and earnings-related data on Collegium Pharma (COLL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
